Literature DB >> 1327559

Isolation and structure elucidation of gymnemic acids, antisweet principles of Gymnema sylvestre.

H M Liu1, F Kiuchi, Y Tsuda.   

Abstract

The structure of gymnemagenin (3 beta,16 beta,21 beta,22 alpha,23,28-hexahydroxy-olean-12-ene), the sapogenin of the antisweet principles of Gymnema sylvestre, was established by X-ray analysis of the 3 beta,23;21 beta,22 alpha-di-O-isopropylidene derivative. On the basis of this result, the structure of deacylgymnemic acid was elucidated as the 3-O-beta-glucuronide from the carbon-13 nuclear magnetic resonance spectra. Five antisweet principles, gymnemic acid-III, -IV, -V, -VIII, and -IX, were isolated in pure states from the hot water extract of leaves of Gymnema sylvestre. Of these, three (GA-III, -IV, and -V) were known, while two (GA-VIII and -IX) were new compounds. The structures of GA-VIII and -IX were elucidated as 3'-O-beta-D-arabino-2-hexulopyranosyl gymnemic acid-III and -IV, respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327559     DOI: 10.1248/cpb.40.1366

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  13 in total

1.  Separation of Bioactive Small Molecules, Peptides from Natural Sources and Proteins from Microbes by Preparative Isoelectric Focusing (IEF) Method.

Authors:  Raja Veerapandian; Anuja Paudyal; Adeline Chang; Govindsamy Vediyappan
Journal:  J Vis Exp       Date:  2020-06-14       Impact factor: 1.355

2.  Abiotic elicitation of gymnemic acid in the suspension cultures of Gymnema sylvestre.

Authors:  Bhuvaneswari Ch; Kiranmayee Rao; Suryakala Gandi; Archana Giri
Journal:  World J Microbiol Biotechnol       Date:  2011-09-04       Impact factor: 3.312

3.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

4.  Biolarvicidal compound gymnemagenol isolated from leaf extract of miracle fruit plant, Gymnema sylvestre (Retz) Schult against malaria and filariasis vectors.

Authors:  Venkatesan Gopiesh Khanna; Krishnan Kannabiran; Govindasamy Rajakumar; Abdul Abdul Rahuman; Thirunavukkarasu Santhoshkumar
Journal:  Parasitol Res       Date:  2011-05-03       Impact factor: 2.289

5.  Elicitation of gymnemic acid production in cell suspension cultures of Gymnema sylvestre R.Br. through endophytic fungi.

Authors:  Vasudeva Reddy Netala; Venkata Subbaiah Kotakadi; Susmila Aparna Gaddam; Sukhendu Bikash Ghosh; Vijaya Tartte
Journal:  3 Biotech       Date:  2016-10-28       Impact factor: 2.406

6.  Gymnemic Acids Inhibit Adhesive Nanofibrillar Mediated Streptococcus gordonii-Candida albicans Mono-Species and Dual-Species Biofilms.

Authors:  Raja Veerapandian; Govindsamy Vediyappan
Journal:  Front Microbiol       Date:  2019-10-11       Impact factor: 5.640

7.  Gymnema sylvestre: A Memoir.

Authors:  Parijat Kanetkar; Rekha Singhal; Madhusudan Kamat
Journal:  J Clin Biochem Nutr       Date:  2007-09       Impact factor: 3.114

8.  Gymnemic acids inhibit hyphal growth and virulence in Candida albicans.

Authors:  Govindsamy Vediyappan; Vincent Dumontet; Franck Pelissier; Christophe d'Enfert
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

Review 9.  Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plant.

Authors:  Pragya Tiwari; B N Mishra; Neelam S Sangwan
Journal:  Biomed Res Int       Date:  2014-01-06       Impact factor: 3.411

10.  Inhibitory Effects of Gymnema (Gymnema sylvestre) Leaves on Tumour Promotion in Two-Stage Mouse Skin Carcinogenesis.

Authors:  Ken Yasukawa; Sakiko Okuda; Yasuhito Nobushi
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-06       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.